Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Total Debt Over TimeElevated
Percentile Rank86
3Y CAGR+96.0%
5Y CAGR+83.8%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
+96.0%/yr
vs +208.9%/yr prior
5Y CAGR
+83.8%/yr
Recent acceleration
Acceleration
-112.9pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
21x
Strong expansion
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
2025$201.06M-11.1%
2024$226.06M+1.6%
2023$222.44M+733.5%
2022$26.69M+290.4%
2021$6.83M-28.6%
2020$9.58M+4689.0%
2019$200000.00-31.7%
2018$293000.00-36.0%
2017$458000.00-13.7%
2016$531000.00-